Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Mark Rutz is active.

Publication


Featured researches published by Mark Rutz.


Archive | 2010

Il-17a antagonists

Michael Naso; Raymond Sweet; Jinquan Luo; Sheng-Jiun Wu; Merle Elloso; Daniela Della Ducata; Robert Rauchenberger; Mark Rutz; Juan Carlos Almagro; Susann Taudte; Bingyuan Wu; Galina Obmolova; Thomas J. Malia


Archive | 2010

IL-17A antibodies

Juan Carlos Almagro; Daniela Della Ducata; Merle Elloso; Jinquan Luo; Thomas J. Malia; Michael Naso; Galina Obmolova; Robert Rauchenberger; Mark Rutz; Raymond Sweet; Susann Taudte; Bingyuan Wu; Sheng-Jiun Wu


Archive | 2009

Toll-like receptor 3 antagonists

Mark Cunningham; Yiqing Feng; Katharine Heeringa; Jinquan Luo; Robert Rauchenberger; Mark Rutz; Lani San Mateo; Robert T. Sarisky; Raymond Sweet; Fang Teng; Alexey Teplyakov; Sheng-Jiun Wu


Archive | 2011

Toll-like receptor 3 antagonists for the treatment of metabolic and cardiovascular diseases

Mark Cunningham; Yiqing Feng; Katharine Heeringa; Jinquan Luo; Robert Rauchenberger; Mark Rutz; Lani San Mateo; Robert T. Sarisky; Vedrana Stojanovic-Susulic; Raymond Sweet; Fang Teng; Alexey Teplyakov; Linda Wu; Sheng-Jiun Wu


Archive | 2013

Polynucleotides encoding Toll-Like Receptor 3 antagonists

Mark Cunningham; Yiqing Feng; Katharine Heeringa; Jinquan Luo; Robert Rauchenberger; Mark Rutz; Lani San Mateo; Robert T. Sarisky; Raymond Sweet; Fang Teng; Alexey Teplyakov; Sheng-Jiun Wu


Archive | 2013

Toll-Like 3 Receptor Antagonists

Mark Cunningham; Yiqing Feng; Katharine Heeringa; Jinquan Luo; Robert Rauchenberger; Mark Rutz; Lani San Mateo; Robert T. Sarisky; Raymond Sweet; Fang Teng; Alexey Teplyakov; Sheng-Jiun Wu


Archive | 2013

Method of treating asthma or reducing inflammatory cell lung inflammation by administering toll-like receptor 3 antibodies

Mark Cunningham; Yiqing Feng; Katharine Heeringa; Jinquan Luo; Robert Rauchenberger; Mark Rutz; Lani San Mateo; Robert T. Sarisky; Raymond Sweet; Fang Teng; Alexey Teplyakov; Sheng-Jiun Wu


Archive | 2017

antagonistas do receptor do tipo toll 3 para o tratamento de doenças metabólicas e cardiovasculares

Alexey Teplyakov; Fang Teng; Jinquan Luo; Katharine Heeringa; Lani San Mateo; Linda Wu; Mark Cunningham; Mark Rutz; Raymond Sweet; Robert Rauchenberger; Robert T. Sarisky; Sheng-Jiun Wu; Vedrana Stojanovic Susulic; Yiqing Feng


Archive | 2014

ANTAGONISTAS IL-17A

Michael Naso; Raymond Sweet; Jinquan Luo; Sheng-Jiun Wu; M. Merle Elloso; Della Ducata Daniela; Robert Rauchenberger; Mark Rutz; Carlos Almagro Juan; Susann Taudte; Bingyuan Wu; Galina Obmolova; Thomas J. Malia


Archive | 2014

Antagonistas del receptor 3 de tipo Toll

Marrk Cunningham; Lani San Mateo; Sarisky Robert T; Raymond Sweeet; Robert Rauchenberger; Mark Rutz; Yiqing Feng; Katharine Heeringa; Jinquan Luo; Fang Teng; Alexey Tepllyakov; Sheng-Jiun Wu

Collaboration


Dive into the Mark Rutz's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Fang Teng

Janssen Pharmaceutica

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Sheng-Jiun Wu

University of Pennsylvania

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Sheng-Jiun Wu

University of Pennsylvania

View shared research outputs
Researchain Logo
Decentralizing Knowledge